MacroGenics: Updating The Investment Thesis [Seeking Alpha]
MacroGenics, Inc. (MGNX)
Last macrogenics, inc. earnings: 11/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.macrogenics.com
Company Research
Source: Seeking Alpha
MacroGenics: Updating The Investment Thesis Summary Positive data on margetuximab in the treatment of HER2+ metastatic breast cancer propelled the stock 130% higher in one day of trading in early February. The company has since executed a secondary offering, and its stock has given back more than half its gains. Even though the most important event of 2019 is behind MacroGenics, the balance of the year will be full of catalysts, including a BLA submission. I always tell the truth. Even when I lie. Today, we take a look at oncology concern MacroGenics ( MGNX Company Overview: MacroGenics is a Rockville, Maryland-based clinical stage biopharmaceutical company focused on the development of antibody-based therapeutics designed to control the human immune response for the treatment of cancer. The company currently has nine candidates in the clinic, ranging from mAbs to bi-specific and tri-specific molecules that are produced from its two platforms: Fc Optimization and DART. MacroGenics has
Show less
Read more
Impact Snapshot
Event Time:
MGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGNX alerts
High impacting MacroGenics, Inc. news events
Weekly update
A roundup of the hottest topics
MGNX
News
- MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call [Yahoo! Finance]Yahoo! Finance
- MacroGenics Announces Date of First Quarter 2024 Financial Results Conference CallGlobeNewswire
- MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.MarketBeat
- Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair [Yahoo! Finance]Yahoo! Finance
- We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely [Yahoo! Finance]Yahoo! Finance
MGNX
Earnings
- 11/6/23 - Beat
MGNX
Sec Filings
- 4/8/24 - Form 4
- 4/8/24 - Form ARS
- 4/8/24 - Form DEFA14A
- MGNX's page on the SEC website